On the 5th May 2023 the WHO declared an end to the Public Health Emergency of International Concern for COVID-19. This page remains as a point of reference for interested parties.
Springer Nature is committed to supporting the global response to COVID-19 enabling fast and direct access to the latest available research, evidence, and data.
The need for continued access to research and learning has never been more important. We recognise our role in this and we continue to work with global organisations, such as the World Health Organisation and the initiative from the White House Office of Science and Technology to make all relevant global research, and data, immediately available. We also continue to work directly with teachers, lecturers, librarians, students and institutions to support their work. See more from our CEO, Frank Vrancken Peeters on our response to the pandemic.
Across the pandemic* we:
- Enabled free access to over 70,000 articles, book chapters, reference works and protocols on our platforms
- Published over 67,000 new COVID-19 articles and supported all researchers in making their underlying experimental data sets available for free and re-use
- Made available, via Research Square, over 10,000 COVID-19 preprint articles
Below, you will find links to key resources, free content and updated information related to COVID-19, alongside key policies and information in supporting remote access and working. Please contact our Customer Services Team if you require further support.
*counted as 2019-2021
